Ken Fisher Fisher Asset Management
AUM
$252B
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
This Quarter Return
+12.6%
1 Year Return
+19.67%
3 Year Return
+104.4%
5 Year Return
+153.45%
10 Year Return
+356.28%
AUM
$252B
AUM Growth
+$252B
(+9%)
Cap. Flow
-$2.39B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
30.76%
Holding
1,093
New
94
Increased
338
Reduced
521
Closed
107
Top Buys
| 1 |
Royal Bank of Canada
RY
|
$696M |
| 2 |
Sony
SONY
|
$424M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$402M |
| 4 |
SAP
SAP
|
$354M |
| 5 |
Spotify
SPOT
|
$353M |
Top Sells
| 1 |
Oracle
ORCL
|
$1.91B |
| 2 |
NVIDIA
NVDA
|
$1.3B |
| 3 |
Salesforce
CRM
|
$1.04B |
| 4 |
Eli Lilly
LLY
|
$886M |
| 5 |
JPMorgan Chase
JPM
|
$868M |
Sector Composition
| 1 | Technology | 25.47% |
| 2 | Financials | 18.4% |
| 3 | Industrials | 9.35% |
| 4 | Healthcare | 9.18% |
| 5 | Communication Services | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $28.4M | 0.01% | 357,860 -53,148 | -13% | -$4.23M |
|
277
First American
FAF
$6.72B
| $28.2M | 0.01% | 458,901 -30,930 | -6% | -$1.9M |
|
278
Taylor Morrison
TMHC
$6.66B
| $28M | 0.01% | 456,676 -789,299 | -63% | -$48.5M |
|
279
Patterson-UTI
PTEN
$2.24B
| $27.9M | 0.01% | 4,709,615 -592,527 | -11% | -$3.51M |
|
280
Helmerich & Payne
HP
$2.08B
| $26.7M | 0.01% | 1,760,541 -91,008 | -5% | -$1.38M |
|
281
Ferrovial SE
FER
$39.4B
| $26.6M | 0.01% | 496,437 +116,229 | +31% | +$6.23M |
|
282
Murphy Oil
MUR
$3.55B
| $26.6M | 0.01% | 1,180,428 -24,297 | -2% | -$547K |
|
283
Baker Hughes
BKR
$44.8B
| $26.2M | 0.01% | 683,408 -74,296 | -10% | -$2.85M |
|
284
Tetra Tech
TTEK
$9.57B
| $26.1M | 0.01% | 725,624 -139,413 | -16% | -$5.01M |
|
285
Texas Capital Bancshares
TCBI
$3.96B
| $25.9M | 0.01% | 326,286 -13,430 | -4% | -$1.07M |
|
286
American Eagle Outfitters
AEO
$2.24B
| $25.7M | 0.01% | 2,676,307 -74,998 | -3% | -$721K |
|
287
UFP Industries
UFPI
$5.91B
| $25.5M | 0.01% | 256,710 -87,141 | -25% | -$8.66M |
|
288
APA Corp
APA
$8.31B
| $25.2M | 0.01% | 1,377,656 -70,594 | -5% | -$1.29M |
|
289
Boot Barn
BOOT
$5.43B
| $25.2M | 0.01% | 165,494 +162,106 | +4,785% | +$24.6M |
|
290
DexCom
DXCM
$29.5B
| $25M | 0.01% | 286,620 -113,251 | -28% | -$9.89M |
|
291
BioCryst Pharmaceuticals
BCRX
$1.74B
| $24.9M | 0.01% | 2,782,489 -269,648 | -9% | -$2.42M |
|
292
Edwards Lifesciences
EW
$47.8B
| $24.7M | 0.01% | 316,392 -9,784,074 | -97% | -$765M |
|
293
Banner Corp
BANR
$2.32B
| $24.5M | 0.01% | 382,478 -14,141 | -4% | -$907K |
|
294
Prestige Consumer Healthcare
PBH
$3.35B
| $24.4M | 0.01% | 305,626 -22,434 | -7% | -$1.79M |
|
295
Cytokinetics
CYTK
$4.23B
| $24.2M | 0.01% | 733,680 -59,778 | -8% | -$1.98M |
|
296
Medtronic
MDT
$119B
| $23.9M | 0.01% | 274,066 -638,446 | -70% | -$55.7M |
|
297
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.2B
| $23.7M | 0.01% | 1,018,357 +31,308 | +3% | +$727K |
|
298
Levi Strauss
LEVI
$8.85B
| $23.5M | 0.01% | 1,272,867 +697,214 | +121% | +$12.9M |
|
299
Independence Realty Trust
IRT
$4.23B
| $23.2M | 0.01% | 1,313,926 -569,745 | -30% | -$10.1M |
|
300
Resideo Technologies
REZI
$5.07B
| $23.1M | 0.01% | 1,046,322 +392,773 | +60% | +$8.66M |
|